Basic Information
| RNALocate ID: | RLID:01001717 |
| RNA Symbol: | hsa-miR-15b-5p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-15b |
| RNA ID: | miRBase:MIMAT0000417 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21363885 |
| Tissue/Cell Line: | Neural progenitor cells |
| Method: | Microarray|qRT-PCR |
| Description: | The miRNAs with nuclear or cytoplasmic dominance are shown in Table 1 (complete data in Supplement 4). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001718 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001719 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001720 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001721 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001722 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001723 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001724 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11001654 | Exosome | Glioblastoma cells | 19011622 |
| RLID:11001655 | Exosome | Lung adenocarcinoma epithelial cell line (A549) | 20615901 |
| RLID:11001656 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001657 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001658 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001659 | Exosome | Breast milk | 22211110 |
| RLID:11001660 | Exosome | Brain tissue | 23382797 |
| RLID:11001661 | Exosome | Plasma | 23663360 |
| RLID:11001662 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001663 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11001664 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001665 | Microvesicle | Glioblastoma cells | 19011622 |
| RLID:11001666 | Microvesicle | Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001667 | Microvesicle | Plasma | 23077538 |
| RLID:11001668 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000070 | Exosome | Endothelial cells|Epithelial cells | |
| RLID-D:11000345 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-15b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-18279 |
| MNDR | hsa-miR-15b-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-18280 |
| MNDR | hsa-miR-15b-5p | Tongue squamous cell carcinoma | MNDR-E-MI-18281 |
| MNDR | hsa-miR-15b-5p | Oral squamous cell carcinoma | MNDR-E-MI-18282 |
| MNDR | hsa-miR-15b-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-18283 |
| MNDR | hsa-miR-15b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-18284 |
| MNDR | hsa-miR-15b-5p | Lymphoma | MNDR-E-MI-18285 |
| MNDR | hsa-miR-15b-5p | Lymphoma non-hodgkin | MNDR-E-MI-18286 |
| MNDR | hsa-miR-15b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-18287 |
| MNDR | hsa-miR-15b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-18288 |
| MNDR | hsa-miR-15b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-18289 |
| MNDR | hsa-miR-15b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-18290 |
| MNDR | hsa-miR-15b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-18291 |
| MNDR | hsa-miR-15b-5p | Acute promyelocytic leukemia | MNDR-E-MI-18292 |
| MNDR | hsa-miR-15b-5p | Breast cancer luminal | MNDR-E-MI-18293 |
| MNDR | hsa-miR-15b-5p | Niemann-pick disease type c | MNDR-E-MI-18294 |
| MNDR | hsa-miR-15b-5p | Lupus nephritis | MNDR-E-MI-18295 |
| MNDR | hsa-miR-15b-5p | Prostate cancer | MNDR-E-MI-18296 |
| MNDR | hsa-miR-15b-5p | Gastric cancer | MNDR-E-MI-18297 |
| MNDR | hsa-miR-15b-5p | Gastric lymphoma | MNDR-E-MI-18298 |
| MNDR | hsa-miR-15b-5p | Alzheimer disease | MNDR-E-MI-18299 |
| MNDR | hsa-miR-15b-5p | Encephalitis japanese | MNDR-E-MI-18300 |
| MNDR | hsa-miR-15b-5p | Intracranial aneurysm | MNDR-E-MI-18301 |
| MNDR | hsa-miR-15b-5p | Esophageal carcinoma | MNDR-E-MI-18302 |
| MNDR | hsa-miR-15b-5p | Dysautonomia familial | MNDR-E-MI-18303 |
| MNDR | hsa-miR-15b-5p | Seizures | MNDR-E-MI-18304 |
| MNDR | hsa-miR-15b-5p | Leukemia | MNDR-E-MI-18305 |
| MNDR | hsa-miR-15b-5p | Huntington disease | MNDR-E-MI-18306 |
| MNDR | hsa-miR-15b-5p | Chorea | MNDR-E-MI-18307 |
| MNDR | hsa-miR-15b-5p | Cardiovascular disease | MNDR-E-MI-18308 |
| MNDR | hsa-miR-15b-5p | Carotid stenosis | MNDR-E-MI-18309 |
| MNDR | hsa-miR-15b-5p | Moyamoya disease | MNDR-E-MI-18310 |
| MNDR | hsa-miR-15b-5p | Lung cancer | MNDR-E-MI-18311 |
| MNDR | hsa-miR-15b-5p | Fragile x syndrome | MNDR-E-MI-18312 |
| MNDR | hsa-miR-15b-5p | Parkinson disease | MNDR-E-MI-18313 |
| MNDR | hsa-miR-15b-5p | Niemann-pick disease | MNDR-E-MI-18314 |
| MNDR | hsa-miR-15b-5p | Basal-like breast cancer | MNDR-E-MI-18315 |
| MNDR | hsa-miR-15b-5p | Thyroid cancer | MNDR-E-MI-18316 |
| MNDR | hsa-miR-15b-5p | Pituitary neoplasms | MNDR-E-MI-18317 |
| MNDR | hsa-miR-15b-5p | Pancreatic cancer | MNDR-E-MI-18318 |
| MNDR | hsa-miR-15b-5p | Malignant melanoma | MNDR-E-MI-18319 |
| MNDR | hsa-miR-15b-5p | Gaucher disease | MNDR-E-MI-18320 |
| MNDR | hsa-miR-15b-5p | Rectum adenocarcinoma | MNDR-E-MI-18321 |
| MNDR | hsa-miR-15b-5p | Nephroblastoma | MNDR-E-MI-18322 |
| MNDR | hsa-miR-15b-5p | Colon cancer | MNDR-E-MI-18323 |
| MNDR | hsa-miR-15b-5p | Colon adenocarcinoma | MNDR-E-MI-18324 |
| MNDR | hsa-miR-15b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-18325 |
| MNDR | hsa-miR-15b-5p | Familial ovarian cancer | MNDR-E-MI-18326 |
| MNDR | hsa-miR-15b-5p | Acromegaly | MNDR-E-MI-18327 |
| MNDR | hsa-miR-15b-5p | Prostate adenocarcinoma | MNDR-E-MI-18328 |
| MNDR | hsa-miR-15b-5p | Carcinoma ductal breast | MNDR-E-MI-18329 |
| MNDR | hsa-miR-15b-5p | Glioblastoma | MNDR-E-MI-18330 |
| MNDR | hsa-miR-15b-5p | Astrocytoma | MNDR-E-MI-18331 |
| MNDR | hsa-miR-15b-5p | Glioma | MNDR-E-MI-18332 |
| MNDR | hsa-miR-15b-5p | Oligodendroglioma | MNDR-E-MI-18333 |
| MNDR | hsa-miR-15b-5p | Neurilemmoma | MNDR-E-MI-18334 |
| MNDR | hsa-miR-15b-5p | Chordoma | MNDR-E-MI-18335 |
| MNDR | hsa-miR-15b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-18336 |
| MNDR | hsa-miR-15b-5p | Osteosarcoma | MNDR-E-MI-18337 |
| MNDR | hsa-miR-15b-5p | Liposarcoma | MNDR-E-MI-18338 |
| MNDR | hsa-miR-15b-5p | Liver cancer | MNDR-E-MI-18339 |
| MNDR | hsa-miR-15b-5p | Cervical adenocarcinoma | MNDR-E-MI-18340 |
| MNDR | hsa-miR-15b-5p | Gastric adenocarcinoma | MNDR-E-MI-18341 |
| MNDR | hsa-miR-15b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-18342 |
| MNDR | hsa-miR-15b-5p | Pituitary adenoma | MNDR-E-MI-18343 |
| MNDR | hsa-miR-15b-5p | Lung squamous cell carcinoma | MNDR-E-MI-18344 |
| MNDR | hsa-miR-15b-5p | Carcinoma lung non-small-cell | MNDR-E-MI-18345 |
| MNDR | hsa-miR-15b-5p | Lung adenocarcinoma | MNDR-E-MI-18346 |
| MNDR | hsa-miR-15b-5p | Adrenocortical cancer | MNDR-E-MI-18347 |
| MNDR | hsa-miR-15b-5p | Ovarian carcinoma | MNDR-E-MI-18348 |
| MNDR | hsa-miR-15b-5p | Bladder urothelial carcinoma | MNDR-E-MI-18349 |
| MNDR | hsa-miR-15b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-18350 |
| MNDR | hsa-miR-15b-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-18351 |
| MNDR | hsa-miR-15b-5p | Carcinoma renal cell | MNDR-E-MI-18352 |
| MNDR | hsa-miR-15b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-18353 |
| MNDR | hsa-miR-15b-5p | Clear cell renal cell carcinoma | MNDR-E-MI-18354 |
| MNDR | hsa-miR-15b-5p | Cholangiocarcinoma | MNDR-E-MI-18355 |
| MNDR | hsa-miR-15b-5p | Esophageal cancer | MNDR-E-MI-18356 |
| MNDR | hsa-miR-15b-5p | Oncocytoma | MNDR-E-MI-18357 |
| MNDR | hsa-miR-15b-5p | Lung small cell carcinoma | MNDR-E-MI-18358 |
| MNDR | hsa-miR-15b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-18359 |
| MNDR | hsa-miR-15b-5p | Heart failure | MNDR-E-MI-18360 |
| MNDR | hsa-miR-15b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-18361 |
| MNDR | hsa-miR-15b-5p | Breast invasive carcinoma | MNDR-E-MI-18362 |
| MNDR | hsa-miR-15b-5p | Hepatocellular carcinoma | MNDR-E-MI-18363 |
| MNDR | hsa-miR-15b-5p | Familiar ovarian carcinoma | MNDR-E-MI-18364 |
| MNDR | hsa-miR-15b-5p | B-cell lymphoma | MNDR-E-MI-18365 |
| MNDR | hsa-miR-15b-5p | Rheumatoid arthritis | MNDR-E-MI-18366 |
| MNDR | hsa-miR-15b-5p | Retinoblastoma | MNDR-E-MI-18367 |
| MNDR | hsa-miR-15b-5p | Barrett's adenocarcinoma | MNDR-E-MI-18368 |
| MNDR | hsa-miR-15b-5p | Hodgkin disease | MNDR-E-MI-18369 |
| MNDR | hsa-miR-15b-5p | Burkitt lymphoma | MNDR-E-MI-18370 |
| MNDR | hsa-miR-15b-5p | Mouth neoplasms | MNDR-E-MI-18371 |
| MNDR | hsa-miR-15b-5p | Psoriasis | MNDR-E-MI-18372 |
| MNDR | hsa-miR-15b-5p | Acute myelogenous leukemia | MNDR-E-MI-18373 |
| MNDR | hsa-miR-15b-5p | Colorectal cancer | MNDR-E-MI-18374 |
| MNDR | hsa-miR-15b-5p | Nasopharynx carcinoma | MNDR-E-MI-18375 |
| MNDR | hsa-miR-15b-5p | Type 2 diabetes mellitus | MNDR-E-MI-18376 |
| MNDR | hsa-miR-15b-5p | Multiple myeloma | MNDR-E-MI-18377 |
| MNDR | hsa-miR-15b-5p | Uterine cervical neoplasms | MNDR-E-MI-18378 |
| MNDR | hsa-miR-15b-5p | Ependymoma | MNDR-E-MI-18379 |
| MNDR | hsa-miR-15b-5p | Cardiac hypertrophy | MNDR-E-MI-18380 |
| MNDR | hsa-miR-15b-5p | Nasopharyngeal cancer | MNDR-E-MI-18381 |
| MNDR | hsa-miR-15b-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-18382 |
| MNDR | hsa-miR-15b-5p | Stroke lacunar | MNDR-E-MI-18383 |
| MNDR | hsa-miR-15b-5p | Barrett's carcinogenesis | MNDR-E-MI-18384 |
| MNDR | hsa-miR-15b-5p | Breast cancer her3+ negative | MNDR-E-MI-18385 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AGO2 | Homo sapiens | RR00055677 |
TOP